Hormone Regulation of Corticotropin-Releasing Factor Receptor 1 in the Female Mouse Brain

被引:0
|
作者
De Guzman, Rose M. [1 ]
Jacobskind, Jason S. [1 ]
Rosinger, Zachary J. [1 ]
Rybka, Krystyna A. [1 ]
Parra, Katherine E. [1 ]
Caballero, Aya L. [1 ]
Sharif, Massoud S. [1 ]
Justice, Nicholas J. [2 ]
Zuloaga, Damian G. [1 ]
机构
[1] SUNY Albany, Dept Psychol, Albany, NY 12222 USA
[2] Univ Texas Hlth Sci Ctr, Brown Fdn Inst Mol Med, Ctr Metab & Degenerat Dis, McGovern Med Sch, Houston, TX USA
关键词
Corticotropin-releasing factor; Stress; Postpartum; Dopamine; Estradiol; Progesterone; Glucocorticoid; PITUITARY-ADRENAL AXIS; MEDIAL PREOPTIC AREA; MATERNAL-BEHAVIOR; PARAVENTRICULAR NUCLEUS; HIPPOCAMPAL NEUROGENESIS; PROLACTIN REGULATION; ESTROGEN-RECEPTORS; SEX-DIFFERENCES; LACTATING RATS; MESSENGER-RNA;
D O I
10.1159/000542751
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: Corticotropin-releasing factor receptor 1 (CRFR1) is a key regulator of neuroendocrine and behavioral stress responses. Previous studies have demonstrated that CRFR1 in certain hypothalamic and preoptic brain areas is modified by chronic stress and during the postpartum period in female mice, although the potential hormonal contributors to these changes are unknown. Methods: This study focused on determining the contributions of hormones associated with stress and the maternal period (glucocorticoids, prolactin, estradiol/progesterone) on CRFR1 levels using a CRFR1-GFP reporter mouse line and immunohistochemistry. Results: Administration of dexamethasone, an agonist of the glucocorticoid receptor, elevated CRFR1 in the anteroventral periventricular nucleus (AVPV/PeN) and paraventricular hypothalamus (PVN) with no changes found in the medial preoptic area (MPOA) or arcuate nucleus. Treatment with prolactin for 5 days elevated CRFR1 levels in the MPOA with no changes in other regions. Finally, we utilized the hormone-simulated pseudopregnancy (HSP) paradigm to mimic changes in estradiol and progesterone across pregnancy and the early postpartum period. Female mice receiving HSP treatment, as well as mice receiving HSP treatment that then underwent 5 days of estrogen withdrawal (EW), showed alterations in CRFR1 relative to control groups that mirrored changes previously reported in postpartum mice. Specifically, CRFR1 levels increased in the AVPV/PeN and decreased in the MPOA and PVN, with no changes found in the arcuate nucleus. HSP- and EW-treated mice also showed decreases in tyrosine hydroxylase-expressing neurons in the AVPV/PeN. Discussion/Conclusion: Overall, these hormone-induced changes in stress-regulating CRFR1 neurons may impact behavioral and neuroendocrine stress responses.
引用
收藏
页码:1139 / 1157
页数:19
相关论文
共 50 条
  • [41] Brain neuropeptide Y and corticotropin-releasing hormone in mediating stress and anxiety
    Thorsell, Annika
    EXPERIMENTAL BIOLOGY AND MEDICINE, 2010, 235 (10) : 1163 - 1167
  • [42] Sex Differences in Corticotropin-Releasing Factor Receptor-1 Action Within the Dorsal Raphe Nucleus in Stress Responsivity
    Howerton, Alexis R.
    Roland, Alison V.
    Fluharty, Jessica M.
    Marshall, Aniko
    Chen, Alon
    Daniels, Derek
    Beck, Sheryl G.
    Bale, Tracy L.
    BIOLOGICAL PSYCHIATRY, 2014, 75 (11) : 873 - 883
  • [43] Effects of olanzapine and quetiapine on corticotropin-releasing hormone release in the rat brain
    Tringali, Giuseppe
    Lisi, Lucia
    De Simone, Maria Laura
    Aubry, Jean-Michel
    Preziosi, Paolo
    Pozzoli, Giacomo
    Navarra, Pierluigi
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2009, 33 (06) : 1017 - 1021
  • [44] Steroid hormone mediated regulation of corticotropin-releasing hormone gene expression
    Ni, Xin
    Nicholson, Richard C.
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2006, 11 : 2909 - 2917
  • [45] Corticotropin-releasing factor receptor type 1, but not type 2, in the ventromedial hypothalamus modulates dopamine release in female rats
    Muramatsu, Tomohiro
    Inoue, Koki
    Iwasaki, Shinichi
    Yamauchi, Tsuneo
    Hayashi, Teruaki
    Kiriike, Nobuo
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2006, 85 (02) : 435 - 440
  • [46] TRANSCRIPTIONAL REGULATION OF HYPOTHALAMIC CORTICOTROPIN-RELEASING FACTOR GENE
    Kageyama, Kazunori
    Suda, Toshihiro
    HORMONES OF THE LIMBIC SYSTEM, 2010, 82 : 301 - 317
  • [47] The Contribution of Corticotropin-Releasing Factor to Gastroprotection
    Filaretova, L. P.
    NEUROCHEMICAL JOURNAL, 2018, 12 (02) : 127 - 129
  • [48] Immunomodulatory role of the corticotropin-releasing factor
    Radulovic, M
    Spiess, J
    ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS, 2001, 49 (01) : 33 - 38
  • [49] Corticotropin-releasing factor, norepinephrine, and stress
    Koob, GF
    BIOLOGICAL PSYCHIATRY, 1999, 46 (09) : 1167 - 1180
  • [50] Androgen regulation of corticotropin-releasing hormone receptor 2 (CRHR2) mRNA expression and receptor binding in the rat brain
    Weiser, Michael J.
    Goel, Nirupa
    Sandau, Ursula S.
    Bale, Tracy L.
    Handa, Robert J.
    EXPERIMENTAL NEUROLOGY, 2008, 214 (01) : 62 - 68